Pricing Log in Create free account

Acrivon Therapeutics, Inc. (ACRV) vs Conexeu Sciences Inc. (CNXU)

Acrivon Therapeutics, Inc. and Conexeu Sciences Inc. are both Biotechnology companies. Acrivon Therapeutics, Inc. and Conexeu Sciences Inc. are of similar size ($67.3M and $65.4M). Across the 9 metrics below, Acrivon Therapeutics, Inc. leads on 6 and Conexeu Sciences Inc. on 3.

Valuation

Metric ACRV CNXU Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.77 10.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.31 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (118.24%) (27.44%) (32.88%)
Free cash flow yield (96.41%) (17.32%) (23.13%)

Profitability

Metric ACRV CNXU Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (64.63%) (458.40%) (51.96%)
Return on assets (57.61%) (354.37%) (46.06%)
Return on invested capital 0.00% (234.60%) 0.00%

Growth

Metric ACRV CNXU Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 15.13% (342.80%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACRV CNXU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 5.31 4.97
Net debt to EBITDA 1.43 1.23 1.01

Dividend

Metric ACRV CNXU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACRV CNXU Biotechnology median
Market cap 67.28m 65.36m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack